CAR-T
New CAR lentivirus range provides high transduction efficiency with stable expression
| 1 min read
This RTP facility will provide increased manufacturing capacity of autologous CAR T-cell products
| 3 min read
Vaccine production, cancer treatment research, and CAR-T therapy development facility finds a home in Amsterdam
| 3 min read
AMSBIO supplies custom CAR-T products that allow the performance of novel immune-oncology assays
| 1 min read
A new era for off-the-shelf cancer immunotherapy
| 4 min read
Paper demonstrates compatibility with downstream manufacturing technologies to help accelerate CAR-T or antibody therapeutics development
| 2 min read
CAR T-cell therapy and bispecific antibodies: Frontiers in cancer immunotherapy
| 1 min read
Page 1 of 1 - 9 Total Items
